The link below refers to a NEW category of statins in the pipeline. The abstract doesn't get into specifics, and the entire paper is available for $96.00 (I'm not buying it). I will bet that the NEW drug is the OLD drug with CoQ10 and perhaps a few other 'additives' designed to poop out a new patent. Remove the **
**http://www.ingentaconnect.com/content/apl/eop/2002/00000003/00000005/art00001
Brooks